LENZ Therapeutics LENZ
NASDAQ LENZ
$3.79 -0.05 (-1.30%)
At close: Oct 1, 2026 · 4:00 PM EDT

LENZ Therapeutics (LENZ) Gross Profit (2025 - 2026)

Updated

LENZ Therapeutics (LENZ) posted Gross Profit of $5.21 million for Q2 2026, up 4.1% from $5 million a year earlier and up 531.0% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Gross Profit (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Profit at LENZ Therapeutics was $11.03 million; for FY2025, it was $18.67 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 LENZ Therapeutics 120.64 Mn 120.64 Mn 5.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.21 Mn
Mar 31, 2026 825,000.00
Jun 30, 2025 5.00 Mn
API Access

LENZ Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=LENZ&period=max&api_key=YOUR_API_KEY